Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interstitial Infusion of IL 13-PE38QQR Cytotoxin in Recurrent Malignant Glioma: Phase I/II Study

NCT00006268 is registered in ClinicalTrials.gov with New Approaches to Brain Tumor Therapy Consortium as lead sponsor.

NCT NCT00006268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interstitial Infusion of IL 13-PE38QQR Cytotoxin in Recurrent Malignant Glioma: Phase I/II Study
Lead sponsor
New Approaches to Brain Tumor Therapy Consortium
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2000
Completion date
March 31, 2005
Enrollment
Not reported
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors